MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)

NCT00703690 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

436

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolic X Syndrome Dyslipidemia

Interventions

DRUG: MK0767
DRUG: Comparator: fenofibrate
DRUG: Comparator: Placebo (unspecified)

Sponsor

Merck Sharp & Dohme LLC